NEOGENOMICS INC — Director's Dealing 2025

Feb 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-02-21

Reporting Person: Olivo Alicia C (EVP, GC & Business Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-23	Common Stock	M	8443	—	Acquired	47857	Direct
2025-02-23	Common Stock	F	2504	—	Disposed	45353	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-21	Stock Option (Right to Buy)	$13.05	A	107450	Acquired	2035-02-21	Common Stock (107450)	Direct
2025-02-21	Restricted Stock Unit	$0	A	63238	Acquired		Common Stock (63238)	Direct
2025-02-23	Restricted Stock Unit	$0	M	8443	Disposed		Common Stock (8443)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$19.12	2026-09-30	Common Stock (1046)	1046	Direct
Stock Option (Right to Buy)	$27.34	2027-05-01	Common Stock (1024)	1024	Direct
Stock Option (Right to Buy)	$48.99	2028-05-01	Common Stock (516)	516	Direct
Stock Option (Right to Buy)	$46.10	2028-08-01	Common Stock (1117)	1117	Direct
Stock Option (Right to Buy)	$9.45	2029-05-01	Common Stock (22222)	22222	Direct
Stock Option (Right to Buy)	$10.05	2029-09-01	Common Stock (55332)	55332	Direct
Stock Option (Right to Buy)	$19.65	2030-05-11	Common Stock (36508)	36508	Direct
Performance Stock Unit	$0		Common Stock (19508)	19508	Direct
Restricted Stock Unit	$0		Common Stock (13006)	13006	Direct
Stock Option (Right to Buy)	$16.45	2034-02-23	Common Stock (42344)	42344	Direct
Performance Stock Unit	$0		Common Stock (25330)	25330	Direct
Restricted Stock Unit	$0		Common Stock (59382)	59382	Direct

Footnotes

F1: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

F2: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

F3: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

F4: On February 21, 2025, Ms. Olivo was granted 107,450 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6: Once vested, the shares of common stock are not subject to expiration.

F7: On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F8: On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vested ratably over the first four anniversary dates of the grant date.

F9: On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F10: On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F11: On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F12: On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F13: On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F14: On May 11, 2023, Ms. Olivo was granted 36,508 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F15: On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stockover the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.

F16: On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F17: On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F18: On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant tothe performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.